News
National Patient Safety Alert: Class 1 Medicines Recall Notification: Recall of Quetiapine Oral Suspension (unlicensed medicine), manufactured by Eaststone Limited due to a potential for overdosing, NatPSA/2026/002/MHRA
Source: MHRA/Gov.uk 29.1.2026 Eaststone Limited is initiating a recall of all batches of quetiapine oral suspension products due to a potential risk of overdose, which could have consequences for...
Class 4 Medicines Defect Notification: Viatris Products Ltd, Arixtra solution for injection, pre-filled syringes, EL(26)A/04
Source: MHRA/Gov.uk 28.1.2026 Viatris has received reports of brown discolouration and blockage in the needle of pre-filled syringes of Arixtra. This quality defect is related to oxidation of the...
What Are Dispex Members Talking About?
January 2026 January in the Dispex WhatsApp Group: Real Questions, Real Answers, Real Support January was a busy month in the Dispex WhatsApp community, with members using the group exactly...
Class 3 Medicines Recall: Glenmark Pharmaceuticals Europe Limited, Fingolimod Glenmark 0.5 mg Hard Capsules, EL(26)A/02
Source: MHRA/Gov.uk 21.1.2026 Glenmark Pharmaceuticals Europe Limited is recalling one batch after stability testing showed out-of-specification results. The batch is being recalled as a precautionary measure following test results...
Class 2 Medicines Recall: Mercury Pharmaceuticals Ltd, Paliperidone Mercury Pharma prolonged-release suspension for injection in pre-filled syringes, EL(26)A/01
Source: MHRA/Gov.uk 20.01.2026 Mercury Pharmaceuticals Ltd is recalling remaining stock of paliperidone pre-filled syringes as a precautionary measure due to Good Manufacturing Practice (GMP) deficiencies cited during a recent...
M6-C Artificial Cervical Disc, Spinal Kinetics LLC: New monitoring requirements for the risk of osteolysis (DSI/2026/001)
Source: MHRA/Gov.uk 15.1.2026 The MHRA has conducted an assessment following reports of osteolysis and early device failure in the literature and is issuing new monitoring requirements for patients implanted with...
Supporting Dispensing Practices For Over Two Decades
Welcome to Dispex Dispex is a trusted and respected name among dispensing professionals, known for delivering high-quality content and expert support. We’ve upheld our reputation through the careful selection of...
Shortage of Co-codamol 30mg/500mg tablets
Source: SPS 13.1.26 High impact The DHSC has published a Tier 3 Medicine Supply Notification for Co-codamol 30mg/500mg tablets. Status: Limited Supply until early June 2026. For further information please...
Dispex Training Options
Dispex is considered to be the leading educational company in the UK, providing professional training, advice and consultancy which purely focuses on dispensing practices- as well as providing profitability tools...
MMRV vaccine now added to the childhood routine schedule
Source: NHS England Bulletin 8.1.26 (issue 371) The MMRV vaccine now replaces the MMR vaccine in the routine schedule for children and is given at 12 months and 18 months....
Ensuring a consistent approach to infection prevention and control
Source: NHS England Bulletin 8.1.26 (issue 371) Winter poses unique challenges. Prevention must continue to be central to plans and IPC is a critical component in reducing risks. The following...
Dispex Tutorial Booking Terms & Conditions
Dispex Ltd-Booking Terms & Conditions: All cancellations must be received in writing or by email. Cancellations of the booking prior to 14 working days of the course date are 100% refundable. Cancellation of...
